289 Results

People

  1. O'Reilly
    O'Reilly
  2. Abou-Alfa
    Abou-Alfa
  3. Motzer
    Motzer
  4. Drilon
    Drilon
  5. D'Angelica
    D'Angelica
  6. Horwitz
    Horwitz
  7. Jarnagin
    Jarnagin
  8. Moskowitz
    Moskowitz
  9. Panageas
    Panageas
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (234)
  2. Solid Tumor Oncology Division (175)
  3. Hematologic Malignancies, Division of (77)
  4. Center for Hematologic Malignancies (63)
  5. Gastrointestinal Oncology Service (51)
  6. Epidemiology and Biostatistics (48)
  7. Center for Pancreatic Cancer Research (47)
  8. Biostatistics Service (46)
  9. GSK Faculty (42)
  10. Genitourinary Oncology Service (38)
  1. "aspartate aminotransferase"
Formats
  1. Journal Article (272)
  2. Review (11)
  3. Research Letter (4)
  4. Guidelines (2)
Groups
  1. Department of Medicine (234)
  2. Solid Tumor Oncology Division (175)
  3. Hematologic Malignancies, Division of (77)
  4. Center for Hematologic Malignancies (63)
  5. Gastrointestinal Oncology Service (51)
  6. Epidemiology and Biostatistics (48)

More Groups

People
  1. Eileen O'Reilly (15)
  2. Ghassan Abou-Alfa (12)
  3. Jedd Wolchok (12)
  4. Nancy Kemeny (12)
  5. Robert Motzer (12)
  6. Alexander Drilon (10)

More People

Years
  1. 2025 (18)
  2. 2024 (37)
  3. 2023 (28)
  4. 2022 (19)
  5. 2021 (9)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Lancet Oncology (21)
  3. Cancer (11)
  4. Clinical Cancer Research (11)
  5. Blood (10)
  6. ESMO Open (7)

More Publications

Publishers
  1. Elsevier Inc. (36)
  2. Elsevier Science, Inc. (33)
  3. American Society of Clinical Oncology (28)
  4. Nature Publishing Group (19)
  5. Oxford University Press (18)
  6. Wiley Blackwell (18)

More Publishers

Results (289)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer
    Journal Article

    Skoulidis, F.; Li, B. T.; Hochmair, M.; Govindan, R.; Vincent, M.; van der Wekken, A. J.; Aransay, N. R.; O’Byrne, K. J.; Girard, N.; Griesinger, F.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Shift from widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T cell therapy: Results from a large retrospective cohort
    Journal Article

    Melica, G.; Luna de Abia, A.; Shah, G. L.; Devlin, S.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; Palomba, M. L.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Journal Article

    Lau, G.; Abou-Alfa, G. K.; Cheng, A. L.; Sukeepaisarnjaroen, W.; Van Dao, T.; Kang, Y. K.; Thungappa, S. C.; Kudo, M.; Sangro, B.; Kelley, R. K.; more...
    Journal of Hepatology (2025)

    Fulltext@MSK | Save
  • Voxel-based dosimetry predicts local tumor progression post (90)Y radiation segmentectomy of colorectal liver metastases
    Journal Article

    Dimopoulos, P. M.; Sotirchos, V. S.; Dunne-Jaffe, C.; Petre, E. N.; Gonen, M.; Zhao, K.; Kirov, A. S.; Crane, C.; D'Angelica, M.; Connell, L. C.; more...
    Clinical Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib
    Journal Article

    Desai, J.; Wagner, A. J.; Carrasco Garcia, I.; Cesari, M.; Gordon, M.; Lin, C. C.; Papai, Z.; Ryan, C. W.; Tap, W. D.; Trent, J. C.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
    Journal Article

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chhabra, S.; Chabowska, M.; Dogan, A.; Falchi, L.; Grieve, C.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: The phase II FRACTION gastric cancer study
    Journal Article

    Ku, G.; Haag, G. M.; Park, H.; Lam, V. K.; George, T. J.; Kim, S. S.; Gutierrez, M.; Shankaran, V.; Stein, S.; Denlinger, C. S.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Phase II study of palbociclib in patients with tumors with CDK4 or CDK6 amplification: Results from the NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocol Z1C
    Journal Article

    O’Hara, M. H.; Jegede, O.; Dickson, M. A.; DeMichele, A. M.; Piekarz, R.; Gray, R. J.; Wang, V.; McShane, L. M.; Rubinstein, L. V.; Patton, D. R.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): A multicentre, open-label, single-arm, phase 2 study
    Journal Article

    Zinzani, P. L.; Izutsu, K.; Mehta-Shah, N.; Barta, S. K.; Ishitsuka, K.; Córdoba, R.; Kusumoto, S.; Bachy, E.; Cwynarski, K.; Gritti, G.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Phase III KEYNOTE-789 study of pemetrexed and platinum with or without pembrolizumab for tyrosine kinase inhibitor-resistant, EGFR-mutant, metastatic nonsquamous non-small cell lung cancer
    Journal Article

    Yang, J. C. H.; Lee, D. H.; Lee, J. S.; Fan, Y.; de Marinis, F.; Iwama, E.; Inoue, T.; Rodríguez-Cid, J.; Zhang, L.; Yang, C. T.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save